The book, which belongs to the series "Nanomedicine and Nanotoxicology", covers a wide range of topics related to engineering nanomaterials for cancer therapy, diagnosis and imaging: from all type of nanoparticles (gold, liposomes-based, polymeric, micellar-based, magnetic, dendrimers-based, porous silicon, or metal/metal oxide), to carbon-based materials (nanotubes, nano-onions or fullererenes), quantum dots and reconfigurable nucleic acid materials.
"It has been a very long process, but we are really proud of the result. We hope that this book can be useful to all those working in functional advanced nanomaterials for detection and therapy of cancer cells and tumours" says Gil Gonçalves.
This book presents a systematic overview of the most relevant nanomaterials and their respective intrinsic properties that have been highly explored by the scientific community and pharmaceutical companies in several different modalities for cancer therapy and bioimaging.
The chapters explore the synergistic effects provided by the different nanostructured materials and highlight the main in vitro and in vivo therapeutic achievements on cancer. This work also provides relevant discussion about the recent progresses and future challenges that nanotechnology faces on the conception of more efficient nanoformulations against primary tumors, circulating cancer cells and metastases.
In Nanooncology you will find:
- The most remarkable therapeutic achievements for oncology.
- A timely and ample revision on the subject.
- The main in vitro and in vivo therapeutic achievements on cancer using nanomaterials.
- More than 450 pages full of studies, images and references written by experts in each field.
About the authors
Gil Gonçalves started working at the ICMAB as a postdoctoral fellow under a prestigious Marie Sklodowska-Curie Grant (Individual Fellowship) funded by the European Comission for the "Development of ultra-sensitive nanotherapeutic anticancer agents for boron neutron capture therapy" (NANOTER, Grant Agreement 708351).
Gerard Tobias leads the research line “Nanoengineering of Carbon and Inorganic Materials” at the ICMAB. He holds a ERC Consolidator grant for his NEST project on "Nanoengineering of radioactive seeds for cancer therapy and diagnosis" since 2017. The NEST project focuses on the preparation of radioactive nanomaterials for the diagnosis and treatment of cancer. Depending on the nature of the employed radioactive materials, it is expected that the nanomaterials prepared will allow both an early diagnosis of tumors and their treatment in a localized manner, thus minimizing damage to healthy tissue.